ACE and peripheral arterial disease: Current guidelines further recommend that PAD patients cease smoking and receive antiplatelet therapy and treatment with statin medications and angiotensin‐converting enzyme (ACE) inhibitors for secondary prevention and cardiovascular risk reduction.